# Monocentric Trial: Stem Cell Emergency Life Threatening Limbs Arteriopathy (SCELTA)

> **NCT02454231** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Florence** · enrollment: 45 (actual)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **BIOLOGICAL:** Transplantation of circulating CD14+CD34+cells
- **BIOLOGICAL:** Transplantation of BM MNC

## Key facts

- **NCT ID:** NCT02454231
- **Lead sponsor:** University of Florence
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2015-05
- **Final completion:** 2015-10
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2017-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02454231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02454231, "Monocentric Trial: Stem Cell Emergency Life Threatening Limbs Arteriopathy (SCELTA)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02454231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*